Wave Life Sciences R&D Day Registration

Start Date:9/28/2023

Start Time:10:00 AM EDT

Duration:90 minutes

Event Description:

Wave Life Sciences is holding a virtual analyst and investor “R&D Day”.

During the event, members from Wave's management team will discuss:

Applying Wave’s best-in-class, multimodal RNA medicines platform to access novel target biology
Extending Wave’s leadership in RNA editing, including new preclinical data for both hepatic and extra-hepatic indications
Wave’s approach to building depth and breadth in its emerging pipeline, while also highlighting WVE-006, the first-ever RNA editing program to enter clinical development

The event will also feature remarks from GSK leaders Tony Wood, Chief Scientific Officer, and Carolyn Buser-Doepner, PhD, Vice President of Novel Human Genetics Research Unit, on Wave’s strategic collaboration with GSK to discover and develop transformative oligonucleotide therapeutics.

If you're already registered for the analyst and investor webcast, click below:

ALREADY REGISTERED?